About us

The profound success of pathogens such as Mycobacterium tuberculosis and HIV in causing disease depends on their ability to successfully utilize the host’s cellular machinery for their own advantage to avert its immune system. Understanding these pathways or processes essential for the life cycle of these pathogens is crucial, as it represents potential targets for new drug strategies.

Lab news and events

Our collaborative work with the lab of Sarah Fortune (Harvard School of Public Health) and Bryan Bryson (MIT) on the mechanism of how GM-CSF signaling controls Mycobacterium tuberculosis infection is published in Nature Communications.

Our collaborative work with the lab of Joost Holthuis is published in Nature Communications.

Our paper that describes the role of Sphingolipids in the entry of M. tuberculosis is now in Biorxiv.

EventPacTB Symposium.
Event2019 FEBS Special Meeting in Sphingolipid Biology.

Fikadu Tafesse smiles while petting an alpaca.

Congratulations to the Tafesse lab. They've received a grant from the Bill & Melinda Gates Foundation for their research project, Nanobodies as a Targeted-Therapeutic Against Mtb

Fikadu Tafesse smiling.

Professor Tafesse is featured as part of OHSU's Onward campaign.

Thumbnail from publication figure. Full illustration can be viewed with the linked journal review.

Flaviviruses, such as Zika and Dengue virus, manipulate the lipid content of host cells to replicate and cause disease. Read our new review.


Tafesse Lab in front of the fountain outside of Mackenzie Hall.
Above: Tafesse Lab 2019

Video: Phagocytosis of Candida albicans by dendritic cells.

Our lab is growing

Tafesse Lab is recruiting. Please see our Contact Us page for details.

Learn about the Dean's Research Scholar Program.

Connect with us